Trial Profile
An Exploratory Study to Investigate the Haemodynamic Effects of Serelaxin (RLX030) in Patients With Compensated Cirrhosis and Portal Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Serelaxin (Primary) ; Terlipressin
- Indications Liver cirrhosis; Portal hypertension
- Focus Pharmacodynamics
- Sponsors Novartis Pharmaceuticals
- 22 Apr 2015 New trial record